A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect Alzheimer's disease at its very earliest stage, even before symptoms appear.
Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on costly brain scans or invasive spinal fluid tests to identify the ...